Crossmark

Reasons to consider low-dose of methimazole as the best option to treat patients with recurrent Graves’ hyperthyroidism

Crossref DOI link: https://doi.org/10.1016/j.rceng.2019.01.006

Published Print: 2019-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

García-Mayor, R.V.
License Information

Text and Data Mining valid from 2019-04-01
More Information

This article is maintained by: Elsevier

Article Title: Reasons to consider low-dose of methimazole as the best option to treat patients with recurrent Graves’ hyperthyroidism

Journal Title: Revista Clínica Española (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rceng.2019.01.006

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.rce.2018.10.007

Content Type: simple-article

Copyright: © 2018 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). All rights reserved.